EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
26 08 2019
Historique:
received: 05 11 2018
accepted: 06 08 2019
entrez: 28 8 2019
pubmed: 28 8 2019
medline: 18 12 2019
Statut: epublish

Résumé

The Polycomb group of proteins is required for the proper orchestration of gene expression due to its role in maintaining transcriptional silencing. It is composed of several chromatin modifying complexes, including Polycomb Repressive Complex 2 (PRC2), which deposits H3K27me2/3. Here, we report the identification of a cofactor of PRC2, EZHIP (EZH1/2 Inhibitory Protein), expressed predominantly in the gonads. EZHIP limits the enzymatic activity of PRC2 and lessens the interaction between the core complex and its accessory subunits, but does not interfere with PRC2 recruitment to chromatin. Deletion of Ezhip in mice leads to a global increase in H3K27me2/3 deposition both during spermatogenesis and at late stages of oocyte maturation. This does not affect the initial number of follicles but is associated with a reduction of follicles in aging. Our results suggest that mature oocytes Ezhip-/- might not be fully functional and indicate that fertility is strongly impaired in Ezhip-/- females. Altogether, our study uncovers EZHIP as a regulator of chromatin landscape in gametes.

Identifiants

pubmed: 31451685
doi: 10.1038/s41467-019-11800-x
pii: 10.1038/s41467-019-11800-x
pmc: PMC6710278
doi:

Substances chimiques

AU022751 protein, mouse 0
Chromatin 0
EZHIP protein, human 0
Histones 0
Oncogene Proteins 0
Recombinant Proteins 0
Polycomb Repressive Complex 2 EC 2.1.1.43

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3858

Commentaires et corrections

Type : CommentIn

Références

Nature. 2011 Jan 20;469(7330):343-9
pubmed: 21248841
Acta Neuropathol. 2018 Aug;136(2):211-226
pubmed: 29909548
Dev Biol. 2017 Apr 15;424(2):198-207
pubmed: 28254491
Development. 2016 Aug 1;143(15):2716-23
pubmed: 27317809
Nat Struct Mol Biol. 2018 Mar;25(3):225-232
pubmed: 29483650
Mol Cell. 2018 May 3;70(3):408-421.e8
pubmed: 29628311
Nature. 2005 Mar 31;434(7033):583-9
pubmed: 15800613
Nat Protoc. 2018 May;13(5):1006-1019
pubmed: 29651053
Clin Epigenetics. 2018 Jul 13;10(1):95
pubmed: 30005706
Cell Rep. 2014 Jun 12;7(5):1456-1470
pubmed: 24857660
Mol Cell. 2014 Jan 9;53(1):49-62
pubmed: 24289921
Genes Dev. 2010 Feb 15;24(4):368-80
pubmed: 20123894
Int J Cancer. 2014 Mar 1;134(5):1112-22
pubmed: 23959973
Genome Biol. 2015 Sep 25;16:209
pubmed: 26408185
Mol Cell. 2018 May 3;70(3):422-434.e6
pubmed: 29681499
Nature. 2017 Jul 27;547(7664):419-424
pubmed: 28723896
Nucleic Acids Res. 2013 Jan 7;41(1):e28
pubmed: 23066101
Nature. 2016 Sep 22;537(7621):558-562
pubmed: 27626379
Nucleic Acids Res. 2009 May;37(9):2940-50
pubmed: 19293275
Oncotarget. 2017 Jan 17;8(3):4062-4078
pubmed: 27845897
Indian J Med Paediatr Oncol. 2012 Jan;33(1):1-6
pubmed: 22754201
Pathol Res Pract. 2009;205(7):466-72
pubmed: 19246164
Cell Rep. 2017 Jun 6;19(10):1987-1996
pubmed: 28591571
Oncotarget. 2017 Feb 7;8(6):10050-10063
pubmed: 28052023
EMBO J. 2017 Nov 2;36(21):3100-3119
pubmed: 28928204
Cell Rep. 2016 Oct 4;17(2):583-595
pubmed: 27705803
Nature. 2004 Sep 2;431(7004):96-9
pubmed: 15318244
Cell. 2015 Jun 4;161(6):1453-67
pubmed: 26046444
Cell. 2010 Oct 29;143(3):470-84
pubmed: 21029866
Curr Biol. 2004 Apr 6;14(7):R284-6
pubmed: 15062124
Mol Cell Proteomics. 2015 Jun;14(6):1435-46
pubmed: 25680957
Methods Mol Biol. 2014;1188:207-26
pubmed: 25059614
Stem Cells. 2011 Feb;29(2):229-40
pubmed: 21732481
Trends Cell Biol. 2018 Mar;28(3):237-253
pubmed: 29217127
Biochim Biophys Acta. 2014 Mar;1839(3):155-68
pubmed: 24091090
Nature. 2009 Jul 23;460(7254):473-8
pubmed: 19525931
Mol Cell. 2018 Mar 1;69(5):840-852.e5
pubmed: 29499137
Mol Cell. 2016 Sep 15;63(6):1066-79
pubmed: 27635762
Cell. 2013 Sep 12;154(6):1370-9
pubmed: 23992847
Science. 2004 Nov 26;306(5701):1571-3
pubmed: 15567867
Nat Commun. 2019 Jan 21;10(1):348
pubmed: 30664650
Nat Commun. 2019 Mar 19;10(1):1262
pubmed: 30890717
Nat Protoc. 2010 Mar;5(3):516-35
pubmed: 20203668
J Reprod Fertil. 1968 Dec;17(3):555-7
pubmed: 5715685
Mol Cell Biol. 2008 Apr;28(8):2825-39
pubmed: 18285465
Nature. 2018 Mar 15;555(7696):392-396
pubmed: 29513657
PLoS One. 2013 Aug 15;8(8):e72689
pubmed: 23967333
Nature. 2008 Apr 17;452(7189):877-81
pubmed: 18354397
Proc Natl Acad Sci U S A. 1972 Jan;69(1):182-6
pubmed: 4621547
Hum Reprod Update. 2018 Sep 1;24(5):556-576
pubmed: 29992283
Genes Dev. 2013 Dec 15;27(24):2663-77
pubmed: 24352422
Science. 2013 Feb 8;339(6120):698-9
pubmed: 23393264
Curr Opin Microbiol. 2015 Aug;26:24-31
pubmed: 25912924
Science. 2018 Feb 23;359(6378):940-944
pubmed: 29348366
Mol Cell. 2018 Jun 21;70(6):1149-1162.e5
pubmed: 29932905
Trends Biochem Sci. 2017 Jul;42(7):531-542
pubmed: 28483375
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2488-93
pubmed: 24550272
Nat Genet. 2004 Dec;36(12):1296-300
pubmed: 15516932
Nat Struct Mol Biol. 2016 Jul;23(7):682-690
pubmed: 27294783
PLoS One. 2011 Apr 21;6(4):e18726
pubmed: 21533035
Mol Cell. 2008 Nov 21;32(4):503-18
pubmed: 19026781
Nat Cell Biol. 2009 Feb;11(2):190-6
pubmed: 19098901
Nat Protoc. 2013 Dec;8(12):2449-70
pubmed: 24232248
Genes Dev. 2014 Sep 15;28(18):2056-69
pubmed: 25228648
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495
Development. 1996 Mar;122(3):815-22
pubmed: 8631259
Nat Struct Mol Biol. 2014 Jun;21(6):569-71
pubmed: 24837194
Genes Dev. 2018 Dec 1;32(23-24):1525-1536
pubmed: 30463900
Dev Cell. 2014 Jul 14;30(1):11-22
pubmed: 24998598

Auteurs

Roberta Ragazzini (R)

Institut Curie, PSL Research University, Sorbonne University, INSERM U934/ CNRS UMR3215, 26, rue d'Ulm, 75005, Paris, France.

Raquel Pérez-Palacios (R)

Institut Curie, PSL Research University, Sorbonne University, INSERM U934/ CNRS UMR3215, 26, rue d'Ulm, 75005, Paris, France.

Irem H Baymaz (IH)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Route 274 M850.03.87 Geert Grooteplein 28, Nijmegen, 6525, GA, Netherlands.

Seynabou Diop (S)

Institut Curie, PSL Research University, Sorbonne University, INSERM U934/ CNRS UMR3215, 26, rue d'Ulm, 75005, Paris, France.

Katia Ancelin (K)

Institut Curie, PSL Research University, Sorbonne University, INSERM U934/ CNRS UMR3215, 26, rue d'Ulm, 75005, Paris, France.

Dina Zielinski (D)

Institut Curie, PSL Research University, Sorbonne University, INSERM U934/ CNRS UMR3215, 26, rue d'Ulm, 75005, Paris, France.
INSERM U900, Mines ParisTech, 26, rue d'Ulm, Paris, France.

Audrey Michaud (A)

Institut Curie, PSL Research University, Sorbonne University, INSERM U934/ CNRS UMR3215, 26, rue d'Ulm, 75005, Paris, France.

Maëlle Givelet (M)

Commissariat à l'énergie atomique et aux énergies alternatives, Institut de radiobiologie cellulaire et moléculaire, Laboratoire des Cellules Souches Germinales, INSERM U967, Fontenay-aux-Roses, 92260, France.

Mate Borsos (M)

Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, D-81377, München, Germany.
Faculty of Biology, Ludwig Maximilians Universität, D-81377, München, Germany.

Setareh Aflaki (S)

Institut Curie, PSL Research University, Sorbonne University, INSERM U934/ CNRS UMR3215, 26, rue d'Ulm, 75005, Paris, France.

Patricia Legoix (P)

ICGex Next-Generation Sequencing Platform, Curie Institute, 26, rue d'Ulm, Paris, France.

Pascal W T C Jansen (PWTC)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Route 274 M850.03.87 Geert Grooteplein 28, Nijmegen, 6525, GA, Netherlands.

Nicolas Servant (N)

Institut Curie, PSL Research University, Sorbonne University, INSERM U934/ CNRS UMR3215, 26, rue d'Ulm, 75005, Paris, France.
INSERM U900, Mines ParisTech, 26, rue d'Ulm, Paris, France.

Maria-Elena Torres-Padilla (ME)

Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, D-81377, München, Germany.
Faculty of Biology, Ludwig Maximilians Universität, D-81377, München, Germany.

Deborah Bourc'his (D)

Institut Curie, PSL Research University, Sorbonne University, INSERM U934/ CNRS UMR3215, 26, rue d'Ulm, 75005, Paris, France.

Pierre Fouchet (P)

Commissariat à l'énergie atomique et aux énergies alternatives, Institut de radiobiologie cellulaire et moléculaire, Laboratoire des Cellules Souches Germinales, INSERM U967, Fontenay-aux-Roses, 92260, France.

Michiel Vermeulen (M)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Route 274 M850.03.87 Geert Grooteplein 28, Nijmegen, 6525, GA, Netherlands.

Raphaël Margueron (R)

Institut Curie, PSL Research University, Sorbonne University, INSERM U934/ CNRS UMR3215, 26, rue d'Ulm, 75005, Paris, France. raphael.margueron@curie.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH